Skip to main content
. 2021 Sep 14;7(6):454–459. doi: 10.1159/000518042

Table 2.

Demographic, clinical characteristics, main therapeutic modalities, and long-term outcomes of 364 children with AA

Variable Frequency, n (%)
Children 364
Gender
 Female 150 (41.2)
 Male 214 (58.8)
Age of onset (mean, SD) 6.6 (3.1)
Unknown 4
Comorbidities
 No 110 (83.4)
 Thyroid disease 11 (8.3)
 Growth retardation 4 (3.0)
 Rheumatic disease 3 (2.3)
 Anemia 2 (1.5)
 Vitiligo 1 (0.8)
 Down syndrome 1 (0.8)
 Unknown 232
Disease location
 Scalp 304 (91.3)
 Eyebrows or eyelashes 8 (2.4)
 Eyebrows and eyelashes 4 (1.2)
 Scalp and eyebrows 5 (1.5)
 Scalp and eyelashes 5 (1.5)
 Scalp, eyelashes, and eyebrows 1 (0.3)
 Totalis 6 (1.8)
 Unknown 31
Plaques
 1–2 123 (66.1)
 3–5 38 (20.4)
 >6 12 (6.5)
 Diffuse 4 (2.2)
 Totalis 7 (3.8)
 Ophiasis 2 (1.1)
 Unknown 178
Nails
 Yes 12 (12.9)
 No 81 (87.1)
 Unknown 271
Family history
 Yes 27 (26.2)
 No 76 (73.8)
 Unknown 261
Atopy
 Yes 32 (24.6)
 No 98 (75.4)
 Unknown 234
Triggering factors
 No 39 (42.4)
 Stress 38 (41.3)
 Viral and other infections 9 (9.8)
 Other (surgery, head lice, etc.) 6 (6.5)
 Unknown 263
Treatment
 No 6 (1.8)
 Topical steroids 232 (69.1)
 Minoxidil 2% 2 (0.6)
 Topical steroids and minoxidil 2% 48 (14.3)
 Anthralin 1% 3 (0.9)
 Topical steroids and anthralin 1% 10 (3.0)
 Topical steroids and minoxidil 2% and anthralin 1% 8 (2.4)
 Systemic steroids 16 (4.8)
 Intralesional triamcinolone acetonide 2 (0.6)
 Topical steroids and calcineurin inhibitors 7 (2.1)
 Calcineurin inhibitors 2 (0.6)
 Unknown 28
Hair regrowth
 Yes 59 (84.3)
 No 11 (15.7)
Percent of hair regrowth
 20% 4 (6.8)
 30% 5 (8.5)
 40% 1 (1.7)
 50% 4 (6.8)
 60% 1 (1.7)
 100% 44 (74.6)
 Unknown 294
Relapse
 Yes 21 (67.7)
 No 10 (32.3)
 Unknown 333

AA, alopecia areata.